| 000 | 01705 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517073130.0 | ||
| 264 | 0 | _c20170117 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1600-6143 | ||
| 024 | 7 |
_a10.1111/ajt.13711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlhamad, T | |
| 245 | 0 | 0 |
_aCheckpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection. _h[electronic resource] |
| 260 |
_bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _cApr 2016 |
||
| 300 |
_a1332-3 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGraft Rejection _xetiology |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aPostoperative Complications |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTransplant Recipients |
| 700 | 1 | _aVenkatachalam, K | |
| 700 | 1 | _aLinette, G P | |
| 700 | 1 | _aBrennan, D C | |
| 773 | 0 |
_tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _gvol. 16 _gno. 4 _gp. 1332-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ajt.13711 _zAvailable from publisher's website |
| 999 |
_c25617976 _d25617976 |
||